SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-23-022421
Filing Date
2023-04-03
Accepted
2023-04-03 20:00:13
Documents
1
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4227
  Complete submission text file 0001209191-23-022421.txt   5748
Mailing Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24
Business Address FITZWILLIAM COURT, 1ST FLOOR LEESON CLOSE DUBLIN 2 L2 D02 YW24 (872) 225-6077
Iterum Therapeutics plc (Issuer) CIK: 0001659323 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BIOMX LTD. 7 PINHAS SAPIR ST., FLOOR 2 NESS ZIONA L3 7414002
Business Address
Puttagunta Sailaja (Reporting) CIK: 0001792314 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38503 | Film No.: 23794668